Showing results (421-430 of 486) with videos related to
Sort By:
Pageof 49
Gut Microbes|April 13, 2026
Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver diseaseMarios Nikolaidis, Chang Hu, Brian D Juran, et al.Science Translational Medicine|February 5, 2025
Translocating gut pathobiont Enterococcus gallinarum induces TH17 and IgG3 anti-RNA-directed autoimmunity in mouse and humanKonrad Gronke, Mytien Nguyen, Helen Fuhrmann, et al.Gastroenterology|July 11, 2024
Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis-Associated Inflammatory Bowel DiseaseHeidrun Dorner, Iris Stolzer, Jochen Mattner, et al.Nature Communications|April 20, 2026
Indirect inhibition of the NLRP3-interleukin-1β axis contributes to the efficacy of JAK1 inhibitors in experimental colitis and human ulcerative colitisBeibei Liu, Marianne R Spalinger, Annalisa Invernizzi, et al.Annals of Hepatology|October 13, 2025
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumabLorenz Kocheise, Jan Kempski, Yunhe Tang, et al.Gut|August 6, 2026
Circulating extracellular vesicles carrying PD-1, PD-L1 and CTLA-4 inform resistance to anti-PD-L1-based therapy in HCCJoão Gorgulho, Ramsha Masood, Gustav Buescher, et al.Journal of Experimental & Clinical Cancer Research : CR|November 8, 2024
Soluble and EV-bound CD27 act as antagonistic biomarkers in patients with solid tumors undergoing immunotherapyJoao Gorgulho, Sven H Loosen, Ramsha Masood, et al.Hepatology (Baltimore, Md.)|March 23, 2011
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9Marcel Janse, Laetitia E Lamberts, Lude Franke, et al.Nature Immunology|August 14, 2023
Short-term dietary changes can result in mucosal and systemic immune depressionFrancesco Siracusa, Nicola Schaltenberg, Yogesh Kumar, et al.JCI Insight|January 10, 2023
Multicytokine-producing CD4+ T cells characterize the livers of patients with NASHAnna Woestemeier, Pasquale Scognamiglio, Yu Zhao, et al.Pageof 49